125 related articles for article (PubMed ID: 32219016)
1. Discovery of potential targets of Triptolide through inverse docking in ovarian cancer cells.
Wu Q; Bao G; Pan Y; Qian X; Gao F
PeerJ; 2020; 8():e8620. PubMed ID: 32219016
[TBL] [Abstract][Full Text] [Related]
2. Triptolide Transcriptionally Represses HER2 in Ovarian Cancer Cells by Targeting NF-κB.
Ou CC; Chen YW; Hsu SC; Sytwu HK; Loh SH; Li JW; Liu JY
Evid Based Complement Alternat Med; 2012; 2012():350239. PubMed ID: 23346199
[TBL] [Abstract][Full Text] [Related]
3. Novel target genes responsive to the anti-growth activity of triptolide in endometrial and ovarian cancer cells.
Li H; Takai N; Yuge A; Furukawa Y; Tsuno A; Tsukamoto Y; Kong S; Moriyama M; Narahara H
Cancer Lett; 2010 Nov; 297(2):198-206. PubMed ID: 20547442
[TBL] [Abstract][Full Text] [Related]
4. Combined Treatment with Triptolide and Tyrosine Kinase Inhibitors Synergistically Enhances Apoptosis in Non-small Cell Lung Cancer H1975 Cells but Not H1299 Cells through EGFR/Akt Pathway.
Tong X; Jiang P; Li Y; Guo L; Zhang HM; Zhang BK; Yan M
Chem Pharm Bull (Tokyo); 2019 Aug; 67(8):864-871. PubMed ID: 31142691
[TBL] [Abstract][Full Text] [Related]
5. Triptolide avoids cisplatin resistance and induces apoptosis via the reactive oxygen species/nuclear factor-κB pathway in SKOV3
Zhong YY; Chen HP; Tan BZ; Yu HH; Huang XS
Oncol Lett; 2013 Oct; 6(4):1084-1092. PubMed ID: 24137468
[TBL] [Abstract][Full Text] [Related]
6. Quantitative Chemical Proteomics Reveals Triptolide Selectively Inhibits HCT116 Human Colon Cancer Cell Viability and Migration Through Binding to Peroxiredoxin 1 and Annexin A1.
Song F; Li J; Shi Q; Wong YK; Liu D; Lin Q; Wang J; Chen X
Adv Biol (Weinh); 2023 Oct; ():e2300452. PubMed ID: 37794608
[TBL] [Abstract][Full Text] [Related]
7. Anti-cancer and Sensibilisation Effect of Triptolide on Human Epithelial Ovarian Cancer.
Hu H; Luo L; Liu F; Zou D; Zhu S; Tan B; Chen T
J Cancer; 2016; 7(14):2093-2099. PubMed ID: 27877225
[No Abstract] [Full Text] [Related]
8. [Effects of Triptolide on MMP-9 Expression and Inducing Apoptosis of Multiple Myeloma Cells by Inhibiting SMYD3].
Xu CB; Shen JZ; Liao B; Fu HY; Lin T
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Aug; 25(4):1063-1068. PubMed ID: 28823269
[TBL] [Abstract][Full Text] [Related]
9. Targets and molecular mechanisms of triptolide in cancer therapy.
Meng C; Zhu H; Song H; Wang Z; Huang G; Li D; Ma Z; Ma J; Qin Q; Sun X; Ma J
Chin J Cancer Res; 2014 Oct; 26(5):622-6. PubMed ID: 25400429
[TBL] [Abstract][Full Text] [Related]
10. Triptolide inhibits cell growth and GRP78 protein expression but induces cell apoptosis in original and radioresistant NPC cells.
Li C; Zhang B; Lv W; Lai C; Chen Z; Wang R; Long X; Feng X
Oncotarget; 2016 Aug; 7(31):49588-49596. PubMed ID: 27391061
[TBL] [Abstract][Full Text] [Related]
11. EMT-related protein expression in polyploid giant cancer cells and their daughter cells with different passages after triptolide treatment.
Wang X; Zheng M; Fei F; Li C; Du J; Liu K; Li Y; Zhang S
Med Oncol; 2019 Aug; 36(9):82. PubMed ID: 31407170
[TBL] [Abstract][Full Text] [Related]
12. Triptolide enhances TRAIL sensitivity of pancreatic cancer cells by activating autophagy via downregulation of PUM1.
Dai H; Jiang Y; Luo Y; Bie P; Chen Z
Phytomedicine; 2019 Sep; 62():152953. PubMed ID: 31128486
[TBL] [Abstract][Full Text] [Related]
13. Triptolide induces apoptosis and inhibits the growth and angiogenesis of human pancreatic cancer cells by downregulating COX-2 and VEGF.
Ma JX; Sun YL; Wang YQ; Wu HY; Jin J; Yu XF
Oncol Res; 2013; 20(8):359-68. PubMed ID: 23924856
[TBL] [Abstract][Full Text] [Related]
14. Role of triptolide as an adjunct chemotherapy for ovarian cancer.
Westfall SD; Nilsson EE; Skinner MK
Chemotherapy; 2008; 54(1):67-76. PubMed ID: 18073474
[TBL] [Abstract][Full Text] [Related]
15. Anti-tumor effects of triptolide on angiogenesis and cell apoptosis in osteosarcoma cells by inducing autophagy via repressing Wnt/β-Catenin signaling.
Li X; Lu Q; Xie W; Wang Y; Wang G
Biochem Biophys Res Commun; 2018 Feb; 496(2):443-449. PubMed ID: 29330051
[TBL] [Abstract][Full Text] [Related]
16. Triptolide induces S phase arrest via the inhibition of cyclin E and CDC25A and triggers apoptosis via caspase- and mitochondrial-dependent signaling pathways in A375.S2 human melanoma cells.
Hung FM; Chen YL; Huang AC; Hsiao YP; Yang JS; Chung MT; Chueh FS; Lu HF; Chung JG
Oncol Rep; 2013 Mar; 29(3):1053-60. PubMed ID: 23314229
[TBL] [Abstract][Full Text] [Related]
17. Synergistic antitumour effects of triptolide plus 10-hydroxycamptothecin onbladder cancer.
Wang T; Ding Y; Yang Y; Wang Z; Gao W; Li D; Wei J; Sun Y
Biomed Pharmacother; 2019 Jul; 115():108899. PubMed ID: 31063955
[TBL] [Abstract][Full Text] [Related]
18. Triptolide inhibits migration and proliferation of fibroblasts from ileocolonic anastomosis of patients with Crohn's disease via regulating the miR‑16‑1/HSP70 pathway.
Chen M; Wang JM; Wang D; Wu R; Hou HW
Mol Med Rep; 2019 Jun; 19(6):4841-4851. PubMed ID: 30942423
[TBL] [Abstract][Full Text] [Related]
19. Effects of triptolide on bone marrow-derived mesenchymal stem cells from patients with multiple myeloma.
Wu H; Wu Y; Ren L; Zhai W; Jiang Y; Guo S; Tao D; Su C; Chen Z; Jiang H
Exp Ther Med; 2019 May; 17(5):3291-3298. PubMed ID: 30988704
[TBL] [Abstract][Full Text] [Related]
20. Triptolide synergistically enhances temozolomide-induced apoptosis and potentiates inhibition of NF-κB signaling in glioma initiating cells.
Sai K; Li WY; Chen YS; Wang J; Guan S; Yang QY; Guo CC; Mou YG; Li WP; Chen ZP
Am J Chin Med; 2014; 42(2):485-503. PubMed ID: 24707876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
